By recruiting granulocytes and activating CD4+ T cells in IBD, IL-1β stimulates the production of pro-inflammatory molecules, such as IL-17A, IL-12, and IFN-γ, aggravating intestinal inflammation (43, 44). Here, IL1B is linked to inflammatory bowel disease.